Lloyd Tillman
8Patents
5h-index
12Co-inventors
60Inventor score
Filing activity: Mar 20, 1997 → Jun 9, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6747014B2 | Compositions and methods for non-parenteral delivery of oligonucleotides | Emerging Cross-Sectional Technologies | 76 | Expired |
| US8691785B2 | Compositions and methods for non-parenteral delivery of oligonucleotides | Emerging Cross-Sectional Technologies | 48 | Active |
| US5879706A | Valaciclovir tablets containing colloidal silicon dioxide | Human Necessities | 16 | Expired |
| US7576067B2 | Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorption | Human Necessities | 9 | Expired |
| US6730679B1 | Pharmaceutical formulations | Human Necessities | 5 | Expired |
| US8377897B2 | Compositions and methods for non-parenteral delivery of oligonucleotides | Chemistry; Metallurgy | 4 | Expired |
| US10174318B2 | Antisense oligonucleotide compositions | Chemistry; Metallurgy | 1 | Active |
| US11859180B2 | Antisense oligonucleotide compositions | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.